JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2022, 71(2):43-56 | DOI: 10.5817/CSF2022-2-43

Community pharmacists and proper administration of inhaled medications

Lucia Masaryková*, Tomáš Tesař, Ľubica Lehocká, Zuzana Koblišková, Michaela Čellárová
Katedra organizácie a riadenia farmácie, Farmaceutická fakulta Univerzity Komenského, Bratislava, SR

Inhaled medications are considered a preferred dosage form of medicine to treat respiratory diseases, such as bronchial asthma and chronic obstructive pulmonary disease (COPD), when bronchodilators or, more precisely, controlled drugs for treatment are used. The main objective of our research was to find out community pharmacists' general knowledge of particular inhalation systems (IS) dispensed in pharmacies. All data necessary for the evaluation have been obtained by an anonymous survey questionnaire carried out between September 2020 and January 2021, which was done both in printed form and online. The questionnaire was self-construction, anonymous, consisting of sociodemographic data (age, gender, residence address - region) and 22 research questions. Both the administration of bronchodilators and inhaled corticosteroids were monitored in the survey. A total of 115 respondents participated in the survey, 86 females (75%) and 29 males (25%). Most of the respondents, 45 (39%), were aged between 23 and 29. The data show that 62 respondents (53.91%) encounter inhaler dispensing several times a day, with the prevalence of aerosol inhalers (MDI), which was confirmed by 78 pharmacists (67.83%). Most of the time, pharmacists meet patients with bronchial asthma, 80 (69.57%), and bronchodilators are prescribed for therapy mainly, 74 (64.35%). In total, 60 respondents (52.17%) provide patients with information on proper administration of inhaled medicines at their request, and only 46 of the respondents (40%) do it without being asked. The survey outcomes show that community pharmacists have minimum knowledge of nebulizers and also of the use of inhalator attachments. The vast majority of participants, 90 (78.26%), say that since they graduated, they haven't attended any education courses aimed at proper administration of inhaled medications as part of their constant education. Up to 95 respondents (82.61%) are interested in IS mock-ups in a pharmacy, 103 pharmacists (89.97%) in information materials for their self-study, and 110 respondents (95.65%) in IS leaflets and brochures for patients. A positive finding of the survey is that the majority of the respondents, 101 (87.83%), are interested in further educating themselves to get knowledge of this matter in the future. Our survey outcomes show that our respondents' knowledge of inhalation systems (IS) is sufficient. Most of the pharmacists who participated in the survey can provide patients with basic information regarding the proper administration of inhaled medicines.

Keywords: community pharmacist; COPD; inhalation systems; administration; bronchial asthma
Grants and funding:

Výskum bol podporený prostredníctvom APVV-18-0425 "Entry and competition in regulated markets: evidence from Slovak pharmacy market".

Received: January 7, 2022; Accepted: February 15, 2022; Published: February 1, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Masaryková L, Tesař T, Lehocká Ľ, Koblišková Z, Čellárová M. Community pharmacists and proper administration of inhaled medications. Čes. slov. farm. 2022;71(2):43-56. doi: 10.5817/CSF2022-2-43.
Download citation

References

  1. Global initiative for asthma. Pocket guide for management and prevention. 2021 [cit.2021-12-07]. Dostupné na: https://ginasthma.org/wp-content/uploads/2021/05/GINA-Pocket-Guide-2021-V2-WMS.pdf
  2. Global initiative for asthma. Global strategy for asthma management and prevention. 2021 [cit. 2021-12- 07]. Dostupné na: https://ginasthma.org/wp-content/uploads/2021/05/GINA-Main-Report-2021-V2-WMS.pdf
  3. Národné centrum zdravotníckych informácii. Zdravotnícka ročenka Slovenskej republiky 2018. Bratislava, 2019. ISBN 978-80-89292-71-4. [cit. 2021-12-07] Dostupné na: http://www.nczisk.sk/Documents/rocenky/2018/Zdravotnicka_rocenka_Slovenskej_republiky_2018.pdf
  4. Národné centrum zdravotníckych informácii. Zdravotnícka ročenka Slovenskej republiky 2019. Bratislava, 2021. ISBN 978-80-89292-77-6. [cit. 2021-12-07] Dostupné na: http://www.nczisk.sk/Documents/rocenky/2019/Zdravotnicka_rocenka_Slovenskej_republiky_2019.pdf(7.12.2021)
  5. ZDRAVOTNICTVÍ ČR: Stručný přehled činnosti oboru pneumologie a ftizeologie za období 2007-2018. Ústav zdravotnických informací a statistiky ČR 2019 [cit. 2021- 12-07]. Dostupné na: www.uzis.cz
  6. Hrubiško M. Astma a jej exacerbácie vo svetle najnovších poznatkov, MediNews. 2014 [cit. 2021-12-07]. Dostupné na: https://www.edukafarm.sk/data/soubory//casopisy/mediNEWS/04-2014/03.pdf
  7. Teřl M., Čáp P., Dvořáková E., Kašák V., Kočí T., Novotná B., Panzner P., Seberová E., Sedlák V., Zindr V. Doporučený postup diagnostiky a léčby brochiálního astmatu. Semily: Geum 2015 [cit. 2021-12-07]. Dostupné na: http://www.csaki.cz
  8. Chronic respiratory diseases - COPD: Definition, WHO [cit. 2021-12-07]. Dostupné na: https://www.who.int/respiratory/copd/definition/en/
  9. Global initiative for Chronic Obstructive Lung Disease. Pocket guide to COPD diagnosis, management, and prevention 2021 [cit. 2021-12-07]. Dostupné na: https://goldcopd.org/wp-content/uploads/2020/12/GOLD-2021-POCKET-GUIDE-v2.0-14Dec20_WMV.pdf
  10. Global initiative for Chronic Obstructive Lung Disease. Global strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary 2021 [cit. 2021-12-07]. Dostupné na: https://goldcopd.org/wpcontent/uploads/2020/11/GOLD-REPORT-2021-v1.1-25Nov20_WMV.pdf
  11. Vondra V., Vondrová I. Diferenciální diagnóza a terapie chronické obstrukční plicní nemoci a astmatu, Interní Medicína 2012; 14(10), 350-356 [cit. 2021-12-07]. Dostupné na: https://www.internimedicina.cz/pdfs/int/2012/10/02.pdf Go to original source... Go to PubMed...
  12. Martínková J., Grim J., Hojdíková H., Chládek J., Chládková J., Kulda K., Libiger J. Farmakologie pro studenty zdravotnických oborů, 2. vydání. Praha: Grada Publishing 2018.
  13. Drugdová M., Krištúfek P., Majer I., Rozborilová E., Tkáčová R. Chronická obštrukčná choroba pľúc. Národné smernice pre prevenciu a terapiu 2011 [cit. 2021-12- 07]. Dostupné na: https://www.copdplatform.com/res/file/national-documents/svkguidelines.pdf
  14. Pauk N. Oxidační stres a CHOPN. Int. Med. 2009; 11(4), 178-181 [cit. 2021-12-07]. Dostupné na: https://www.solen.cz/pdfs/int/2009/04/08.pdf
  15. Global initiative for Asthma, Global initiative for Chronic Obstructive Lung Disease. Diagnosis and initial treatment of Asthma, COPD and Asthma - COPD Overlap. Updated 2017 [cit. 2021-12-07]. Dostupné na: https://ginasthma.org/wpcontent/uploads/2019/11/GINA-GOLD-2017-overlap-pocket-guide-wms-2017-ACO.pdf
  16. Knight A. Managing the overlap of asthma and chronic obstructive pulmonary disease. Australian Prescriber 2020; 43(1), 7-11 [cit. 2021-12-07]. Dostupné na: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7026918/ Go to original source... Go to PubMed...
  17. Pauk N. Diagnostika a terapie překryvu astmatu a CHOPN (ACO). Int. Medicína pro praxi 2019; 21(1), 8-13 [cit. 2021-12-07]. Dostupné na: https://www.internimedicina.cz/pdfs/int/2019/01/02.pdf Go to original source...
  18. Hesso I., Gebara S. N., Kayyali R. Impact of community pharmacists in COPD management: Inhalation technique and medication adherence. Respiratory Medicine 2016; 118, 22-30 [cit. 2021-12-07]. Dostupné na: http://www.sciencedirect.com Go to original source... Go to PubMed...
  19. Wu A. A Pharmacist's Role in the Management of Chronic Obstructive Pulmonary Disease. US Pharmacist. 2016; 41(7), 42-46 [cit. 2021-12-07]. Dostupné na: https://www.uspharmacist.com/article/a-pharmacists-role-in-themanagement-of-chronic-obstructive-pulmonarydisease
  20. Castillo D., Burgos F., Gascón M. P. The Role of Community Pharmacies in Respiratory Disease Control. Archivos de Bronconeumologia 2015; 51(9), 429-430 [cit. 2021- 12-07]. Dostupné na: https://www.archbronconeumol.org/en-pdf-S1579212915002748 Go to original source...
  21. Xiaona J., Shuang Z., Daohuang L., Xia Z., Ying Z., Yi-Min C. Effect of pharmacist-led interventions on medication adherence and inhalation technique in adult patients with asthma or COPD: A systematic review and meta-analysis. J. Clin. Pharm. Therap. 2020; 45, 904-917 [cit. 2021-12-07]. Dostupné na: https://onlinelibrary.wiley.com/doi/full/10.1111/jcpt.13126(7.12.2021) Go to original source... Go to PubMed...
  22. Národné centrum zdravotníckych informácií. Zdravotnícka ročenka Slovenskej republiky 2020. Bratislava 2021 [cit. 2022-02-07]. Dostupné na: https://www.nczisk.sk/Documents/rocenky/2020/Zdravotnicka_rocenka_Slovenskej_republiky_2020.pdf
  23. Bridgeman M. B., Wilken L. A. Essential Role of Pharmacists in Asthma Care and Management. J. Pharm. Pract. 2021; 34(1), 149-162 [cit. 2021-12-07]. Dostupné na: https://journals.sagepub.com/doi/full/10.1177/0897190020927274 Go to original source... Go to PubMed...
  24. Hudd R. T. R. Emerging role of pharmacists in managing patients with chronic obstructive pulmonary disease. Am. Soc. Health-System Pharmacists 2020; 77(19), 1625- 1630 [cit. 2021-12-07]. Dostupné na: https://academic.oup.com/ajhp/article/77/19/1625/5875380 Go to original source... Go to PubMed...




Czech and Slovak Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.